Non-human primate (NHP) toxicology study validates the CAPTN-3 masking strategy, with IM1240 showing an 8-fold longer half-life, 16-fold greater exposure, and a markedly improved cytokine-release safety profile compared to the non-capped variant IM1240 demonstrated anti-tumor activity across PD-1- and chemotherapy-resistant patient-derived tumor samples in head and neck, bladder, and lung cancers, with the NKG2A arm identified as a key contributor to this anti-tumor efficacy IM1240 induced immune cell structures associated with effective anti-tumor responses and a favorable prognosis in patient-derived non-small cell lung cancer (NSCLC) explants REHOVOT, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- ...

$4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrantsSEATTLE, June 11, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced that it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,363,638 shares (the "Shares") of its common stock, par value $0.18 per share ("Common Stock") (or common stock equivalents in lieu thereof), Series A warrants to purchase up ...

Issued on behalf of Starfighters Space, Inc.A historic IPO is about to hand the orbital economy its first public price tag — and that single number will echo across every space ticker on the board.BREVARD COUNTY, Fla., June 11, 2026 /PRNewswire/ -- American News Group News Commentary — In private markets, value is whispered. In public markets, it is shouted — printed on a ticker, updated by the second, available to everyone. The commercial space sector is about to make that transition at its very summit. As reported, SpaceX is set to price its initial public offering in this window, ...

XIAMEN, China, June 10, 2026 /PRNewswire/ -- POP Culture Group Co., Ltd. (Nasdaq: CPOP, "POP Culture" or the "Company"), today announced its unaudited financial results for six months ended December 31, 2025. During the reporting period, the Company achieved significant growth in its core business, with strong revenue expansion, improved gross profit, and continued optimization of its cost structure. Overall, the Company demonstrated a sound and favorable trajectory of high-speed growth, reflecting strong operational resilience and substantial growth potential.